$62.94
Add to Cart
Milgamma® protekt vitamin B1 tablets, 30 pcs
10 available
Details
Shipping: Australia: $1952.00 (more destinations)
Condition: Brand new
Returns: does not accept (more)
Milgamma® protekt vitamin B1 tablets, 30 pcs
milgamma® protekt with benfotiamine – For the treatment of nerve damage resulting from a vitamin B1 deficiency
To treat vitamin B1 deficiency. In this way, foot problems such as tingling, burning or numbness can be alleviated.
Your choice for nerve damage due to vitamin B1 deficiency
Tingling, burning or painful feet rob many people of sleep at night. Nerve damage, so-called neuropathy, can be a possible cause. Those affected often do not know that a vitamin B1 deficiency can also trigger or worsen these neuropathies. If you compensate for this deficit, you can alleviate the symptoms in your feet. People with diabetes in particular can have an increased risk of vitamin B1 deficiency and neuropathies. The increased blood sugar can damage the nerves while promoting a vitamin B1 deficiency.
Preparation with the high-dose vitamin B1 active ingredient benfotiamine
Corrects vitamin B1 deficiency and can therefore relieve symptoms such as tingling, burning and numbness in the feet
Fat-soluble vitamin B1 precursor with 5 times higher bioavailability than normal vitamin B1 1
Well tolerated
Also suitable for long-term use
Lactose free and gluten free
milgamma® protekt can compensate for the vitamin B1 deficiency and alleviate the symptoms. What is special is the active ingredient benfotiamine. The fat-soluble precursor of vitamin B1 is absorbed by the body 5 times better than “simple” vitamin B1 (thiamine) 1 .
What many people don't know is that a vitamin B1 deficiency can also cause or worsen nerve damage. It is particularly common in diabetes, and vitamin B1 is increasingly excreted via the kidneys. Diabetics with neuropathies should therefore definitely compensate for the vitamin B1 deficit.
If you have diabetes, there is an increased risk of vitamin B1 deficiency
Significantly lower vitamin B1 concentration in the blood of diabetics 2 than in healthy people
Increased excretion of vitamin B1 via the kidneys 2
Type 2 diabetics often consume less vitamin B1 from their diet compared to healthy people. 3
The increased need for vitamin B1 often cannot be met through a normal diet.
1 Schreeb et al. Comparative bioavailability of two Vitamin B1 preparations: benfotiamine and thiamine mononitrate. Eur J Clin Pharmacol 1997; 52 (4): 319–320.
2 Thornalley PJ, et al. High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease. Diabetologia 2007 Oct; 50 (10): 2164–2170.
3 Wong et al. Daily intake of thiamine correlates with the circulating level of endothelial progenitor cells and the endothelial function in patients with type II diabetes, Mol Nutr Food Res 2008 Dec; 52 (12): 1421–1427.
Mandatory information:
milgamma® protekt. Active ingredient: Benfotiamine 300 mg. Areas of application: Therapy or prophylaxis of clinical vitamin B1 deficiency states, if these cannot be remedied through nutrition; Treatment of neuropathies and cardiovascular. Sturgeon, i.e. caused by vitamin B1 deficiency. For information about risks and side effects, read the package leaflet and ask your doctor or pharmacy. WÖRWAG Pharma GmbH & Co. KG, 71034 Böblingen
Application
Unless otherwise prescribed, take 1 film-coated tablet once daily.
Take 1 film-coated tablet daily without chewing with a little liquid.
To treat neuropathies resulting from a vitamin B1 deficiency, milgamma® protekt should be taken for at least 3 weeks.
Suitable for long-term use.
Please do not use this medicine after the expiry date stated on the pack or outer packaging. The expiry date refers to the last day of the specified month.
Hints
Keep out of reach of children!
ingredients
Active ingredient
1 tablet contains: 300 mg benfotiamine
Other ingredients: Microcrystalline cellulose, talc, povidone (K30), colloidal silicon dioxide, croscarmellose sodium, higher chain partial glycerides, hypromellose, titanium dioxide, polyethylene glycol, saccharin sodium
Address of the provider/manufacturer
Wörwag Pharma GmbH & Co. KG
Flugfeld-Allee 24
71034 Böblingen
The picture is for illustration only. The packaging can be changed by the manufacturer. All packs include English informational leaflet.
DISCLAMER!!!! This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
milgamma® protekt with benfotiamine – For the treatment of nerve damage resulting from a vitamin B1 deficiency
To treat vitamin B1 deficiency. In this way, foot problems such as tingling, burning or numbness can be alleviated.
Your choice for nerve damage due to vitamin B1 deficiency
Tingling, burning or painful feet rob many people of sleep at night. Nerve damage, so-called neuropathy, can be a possible cause. Those affected often do not know that a vitamin B1 deficiency can also trigger or worsen these neuropathies. If you compensate for this deficit, you can alleviate the symptoms in your feet. People with diabetes in particular can have an increased risk of vitamin B1 deficiency and neuropathies. The increased blood sugar can damage the nerves while promoting a vitamin B1 deficiency.
Preparation with the high-dose vitamin B1 active ingredient benfotiamine
Corrects vitamin B1 deficiency and can therefore relieve symptoms such as tingling, burning and numbness in the feet
Fat-soluble vitamin B1 precursor with 5 times higher bioavailability than normal vitamin B1 1
Well tolerated
Also suitable for long-term use
Lactose free and gluten free
milgamma® protekt can compensate for the vitamin B1 deficiency and alleviate the symptoms. What is special is the active ingredient benfotiamine. The fat-soluble precursor of vitamin B1 is absorbed by the body 5 times better than “simple” vitamin B1 (thiamine) 1 .
What many people don't know is that a vitamin B1 deficiency can also cause or worsen nerve damage. It is particularly common in diabetes, and vitamin B1 is increasingly excreted via the kidneys. Diabetics with neuropathies should therefore definitely compensate for the vitamin B1 deficit.
If you have diabetes, there is an increased risk of vitamin B1 deficiency
Significantly lower vitamin B1 concentration in the blood of diabetics 2 than in healthy people
Increased excretion of vitamin B1 via the kidneys 2
Type 2 diabetics often consume less vitamin B1 from their diet compared to healthy people. 3
The increased need for vitamin B1 often cannot be met through a normal diet.
1 Schreeb et al. Comparative bioavailability of two Vitamin B1 preparations: benfotiamine and thiamine mononitrate. Eur J Clin Pharmacol 1997; 52 (4): 319–320.
2 Thornalley PJ, et al. High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease. Diabetologia 2007 Oct; 50 (10): 2164–2170.
3 Wong et al. Daily intake of thiamine correlates with the circulating level of endothelial progenitor cells and the endothelial function in patients with type II diabetes, Mol Nutr Food Res 2008 Dec; 52 (12): 1421–1427.
Mandatory information:
milgamma® protekt. Active ingredient: Benfotiamine 300 mg. Areas of application: Therapy or prophylaxis of clinical vitamin B1 deficiency states, if these cannot be remedied through nutrition; Treatment of neuropathies and cardiovascular. Sturgeon, i.e. caused by vitamin B1 deficiency. For information about risks and side effects, read the package leaflet and ask your doctor or pharmacy. WÖRWAG Pharma GmbH & Co. KG, 71034 Böblingen
Application
Unless otherwise prescribed, take 1 film-coated tablet once daily.
Take 1 film-coated tablet daily without chewing with a little liquid.
To treat neuropathies resulting from a vitamin B1 deficiency, milgamma® protekt should be taken for at least 3 weeks.
Suitable for long-term use.
Please do not use this medicine after the expiry date stated on the pack or outer packaging. The expiry date refers to the last day of the specified month.
Hints
Keep out of reach of children!
ingredients
Active ingredient
1 tablet contains: 300 mg benfotiamine
Other ingredients: Microcrystalline cellulose, talc, povidone (K30), colloidal silicon dioxide, croscarmellose sodium, higher chain partial glycerides, hypromellose, titanium dioxide, polyethylene glycol, saccharin sodium
Address of the provider/manufacturer
Wörwag Pharma GmbH & Co. KG
Flugfeld-Allee 24
71034 Böblingen
The picture is for illustration only. The packaging can be changed by the manufacturer. All packs include English informational leaflet.
DISCLAMER!!!! This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
LT, Panevezys
